Previously, Renault had counted the key varieties of Pfizer, Novartis and Merck's listing in China. This article will continue to talk with you about the key varieties of Roche's listing in China.
Referring to Roche, it is estimated that we first think of Roche's blood glucose meter? ! Yes, Roche from Basel, Switzerland is not only a global leader in the pharmaceutical business, but also a world-class position in the diagnostic business.
Roche has a history of 120 years. As one of the world's top 500 companies and the world's largest biotechnology company, Roche Pharmaceuticals has the world's leading pharmaceuticals in the areas of anti-tumor, immune, anti-infective and ophthalmic treatments. In particular, Roche's three anti-tumor drugs, rituximab, avidin and Herceptin, have remained in the anti-tumor field because they have been listed on the world's best-selling anti-cancer drug list for many years. It is reported that in 2016, Roche's pharmaceutical business revenue was 39.252 billion US dollars, while the global sales of American Luohua, Avastin and Herceptin totaled as high as 21.1 billion US dollars.
2016 Roche Top Ten Best Selling Drugs
After Renault’s review of Roche’s top 10 best-selling drugs in 2016, Roche’s total sales of the top 10 best-selling drugs in 2016 were $30.721 billion. In addition to Kadcyla's global sales approved in February 2013, the sales of the remaining nine drugs exceeded $1 billion. Among the top 10 best-selling drugs are six anti-tumor drugs (of which rituximab can also be used as an immune system), two for immunization, one for cardiovascular and one for ophthalmology (see Table 1 for details). Among them, the cardiovascular drug Activase is the only steroid drug approved by the US FDA for ischemic stroke. It is worth mentioning that among the top 10 best-selling drugs mentioned above, except for Tarceva, which is a small molecule drug, the other 9 are biological drugs. It can be seen that Roche has great strength in biotechnology and anti-tumor fields.
Table 1 Roche's top ten best-selling brand medicines in 2016
Remarks: Xolair was jointly developed by Roche and Novartis. Its global sales in 2016 was 2.356 billion US dollars, and Novartis sales were 835 million US dollars;
Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshihealths.com